Literature DB >> 3902770

Effects of detraining on responses to submaximal exercise.

E F Coyle, W H Martin, S A Bloomfield, O H Lowry, J O Holloszy.   

Abstract

Seven endurance-trained subjects were studied 12, 21, 56, and 84 days after cessation of training. Heart rate, ventilation, respiratory exchange ratio, and blood lactate concentration during submaximal exercise of the same absolute intensity increased (P less than 0.05) progressively during the first 56 days of detraining, after which a stabilization occurred. These changes paralleled a 40% decline (P less than 0.001) in mitochondrial enzyme activity levels and a 21% increase in total lactate dehydrogenase (LDH) activity (P less than 0.05) in trained skeletal muscle. After 84 days of detraining, the experimental subjects' muscle mitochondrial enzyme levels were still 50% above, and LDH activity was 22% below, sedentary control levels. The blood lactate threshold of the detrained subjects occurred at higher absolute and relative (i.e., 75 +/- 2% vs. 62 +/- 3% of maximal O2 uptake) exercise intensities in the subjects after 84 days of detraining than in untrained controls (P less than 0.05). Thus it appears that a portion of the adaptation to prolonged and intense endurance training that is responsible for the higher lactate threshold in the trained state persists for a long time (greater than 85 days) after training is stopped.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902770     DOI: 10.1152/jappl.1985.59.3.853

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  31 in total

1.  A reduction in training volume and intensity for 21 days does not impair performance in cyclists.

Authors:  G J Rietjens; H A Keizer; H Kuipers; W H Saris
Journal:  Br J Sports Med       Date:  2001-12       Impact factor: 13.800

Review 2.  Detraining: loss of training-induced physiological and performance adaptations. Part II: Long term insufficient training stimulus.

Authors:  I Mujika; S Padilla
Journal:  Sports Med       Date:  2000-09       Impact factor: 11.136

3.  Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle.

Authors:  Søren Nielsen; Camilla Scheele; Christina Yfanti; Thorbjörn Akerström; Anders R Nielsen; Bente K Pedersen; Matthew J Laye; Matthew Laye
Journal:  J Physiol       Date:  2010-10-15       Impact factor: 5.182

4.  Effect of training with different intensities and volumes on muscle fibre enzyme activity and cross sectional area in the m. triceps brachii.

Authors:  Terje F Gjøvaag; Hans A Dahl
Journal:  Eur J Appl Physiol       Date:  2008-07       Impact factor: 3.078

5.  The regulation of skeletal muscle fatigability and mitochondrial function by chronically elevated interleukin-6.

Authors:  Brandon N VanderVeen; Dennis K Fix; Ryan N Montalvo; Brittany R Counts; Ashley J Smuder; E Angela Murphy; Ho-Jin Koh; James A Carson
Journal:  Exp Physiol       Date:  2019-01-15       Impact factor: 2.969

6.  Effects of mild-exercise training cessation in human skeletal muscle.

Authors:  Jonny St-Amand; Mayumi Yoshioka; Yuichiro Nishida; Takuro Tobina; Naoko Shono; Hiroaki Tanaka
Journal:  Eur J Appl Physiol       Date:  2011-06-17       Impact factor: 3.078

Review 7.  Strategies to improve running economy.

Authors:  Kyle R Barnes; Andrew E Kilding
Journal:  Sports Med       Date:  2015-01       Impact factor: 11.136

Review 8.  The effect of detraining and reduced training on the physiological adaptations to aerobic exercise training.

Authors:  P D Neufer
Journal:  Sports Med       Date:  1989-11       Impact factor: 11.136

9.  Effects of two high-intensity intermittent training programs interspaced by detraining on human skeletal muscle and performance.

Authors:  J A Simoneau; G Lortie; M R Boulay; M Marcotte; M C Thibault; C Bouchard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987

Review 10.  Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit.

Authors:  Jules A A C Heuberger; Joost M Cohen Tervaert; Femke M L Schepers; Adriaan D B Vliegenthart; Joris I Rotmans; Johannes M A Daniels; Jacobus Burggraaf; Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.